Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3557)
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,638
Price
$276.32
Total Value
$728.92K
Shares Held After
85,096
% of Holdings
3.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
5,103
Price
$275.28
Total Value
$1.40M
Shares Held After
87,734
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
12,378
Price
$23.86
Total Value
$295.34K
Shares Held After
639,076
% of Holdings
1.9%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
6,228
Price
$1.93
Total Value
$12.02K
Shares Held After
73,125
% of Holdings
7.8%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
523
Price
$18.04
Total Value
$9.43K
Shares Held After
209,641
% of Holdings
0.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,108
Price
$18.04
Total Value
$56.07K
Shares Held After
210,164
% of Holdings
1.5%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
6,217
Price
$23.86
Total Value
$148.34K
Shares Held After
211,513
% of Holdings
2.9%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
942
Price
$28.90
Total Value
$27.22K
Shares Held After
170,273
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
859
Price
$28.16
Total Value
$24.19K
Shares Held After
171,215
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,437
Price
$26.98
Total Value
$38.77K
Shares Held After
172,074
% of Holdings
0.8%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
353
Price
$69.06
Total Value
$24.38K
Shares Held After
70,990
% of Holdings
0.5%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,995
Price
$4.51
Total Value
$18.04K
Shares Held After
35,943
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,896
Price
$4.51
Total Value
$44.67K
Shares Held After
89,104
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,815
Price
$4.51
Total Value
$12.71K
Shares Held After
55,569
% of Holdings
4.8%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
33,687
Price
$7.00
Total Value
$235.96K
Shares Held After
170,970
% of Holdings
16.5%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
1,300
Price
$36.68
Total Value
$47.68K
Shares Held After
459,859
% of Holdings
0.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,436
Price
$35.96
Total Value
$375.28K
Shares Held After
461,159
% of Holdings
2.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
46,517
Price
$35.11
Total Value
$1.63M
Shares Held After
471,595
% of Holdings
9.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
1,846
Price
$486.35
Total Value
$897.80K
Shares Held After
55,570
% of Holdings
3.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
260
Price
$486.35
Total Value
$126.45K
Shares Held After
46,763
% of Holdings
0.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,410
Price
$489.00
Total Value
$1.18M
Shares Held After
17,559
% of Holdings
12.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,500
Price
$486.35
Total Value
$1.22M
Shares Held After
19,969
% of Holdings
11.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
700
Price
$275.00
Total Value
$192.50K
Shares Held After
92,837
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
223
Price
$486.35
Total Value
$108.46K
Shares Held After
6,981
% of Holdings
3.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
945
Price
$486.35
Total Value
$459.60K
Shares Held After
13,659
% of Holdings
6.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
668
Price
$486.35
Total Value
$324.88K
Shares Held After
18,432
% of Holdings
3.5%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
11,219
Price
$113.82
Total Value
$1.28M
Shares Held After
33,938
% of Holdings
24.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8
Price
$93.49
Total Value
$747.92
Shares Held After
666,195
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,501
Price
$92.81
Total Value
$139.31K
Shares Held After
666,203
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,293
Price
$91.76
Total Value
$302.17K
Shares Held After
667,704
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,434
Price
$90.39
Total Value
$491.18K
Shares Held After
670,997
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
19,764
Price
$89.78
Total Value
$1.77M
Shares Held After
676,431
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$520.00
Total Value
$520.00K
Shares Held After
4,190
% of Holdings
19.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
3,161
Price
$36.46
Total Value
$115.25K
Shares Held After
459,859
% of Holdings
0.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
61,547
Price
$36.13
Total Value
$2.22M
Shares Held After
463,020
% of Holdings
11.7%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
47,918
Price
$44.50
Total Value
$2.13M
Shares Held After
616,106
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,425
Price
$274.90
Total Value
$666.63K
Shares Held After
93,537
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
930
Price
$269.50
Total Value
$250.64K
Shares Held After
95,962
% of Holdings
1.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,674
Price
$268.67
Total Value
$449.75K
Shares Held After
96,892
% of Holdings
1.7%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,891
Price
$267.37
Total Value
$505.60K
Shares Held After
98,566
% of Holdings
1.9%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
4,339
Price
$266.62
Total Value
$1.16M
Shares Held After
100,457
% of Holdings
4.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
1,604
Price
$265.54
Total Value
$425.92K
Shares Held After
104,796
% of Holdings
1.5%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
900
Price
$264.60
Total Value
$238.14K
Shares Held After
106,400
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
62
Price
$263.05
Total Value
$16.31K
Shares Held After
107,300
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
373
Price
$271.09
Total Value
$101.12K
Shares Held After
0
% of Holdings
100.0%
Showing 1401–1450 of 3557 transactions (page 29 of 72)